First Alzheimer's drug to slow disease gets full FDA approval
The FDA has given full approval to a landmark drug to treat Alzheimer's disease. This clears the way for Medicare and other insurance plans to begin covering the treatment. Bradley Blackburn reports for CBS New York. Read more: https://cbsloc.al/46E3fUj